Please assess the completion status of the following clinical trial:

Trial Title: Dexmedetomidine Combined With Lidocaine Infusion Affect PONV

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* American Society of Anesthesiologists (ASA) physical statusⅠand Ⅱ~* Aged 40-60 years~* Scheduled for elective laparoscopic hysterectomy~Exclusion Criteria:~* History of allergy to local anesthetics~* BMI\>30~* Severe respiratory disease~* Renal or hepatic insufficiency~* History of preoperative opioids medication and psychiatric~* preoperative bradycardia~* preoperative atrioventricular block~* Subjects who experienced severe hypotension (mean arterial pressure \[MAP\] \<60 mmHg) or bradycardia (heart rate \[HR\] \<40 bpm), urticaria, or arrhythmia during lidocaine and dexmedetomidine infusion period

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Dexmedetomidine Combined With Lidocaine Infusion Affect PONV (Type: EXPERIMENTAL): None
- Effect of infusion saline on PONV (Type: EXPERIMENTAL): None
- Effect of infusion lidocaine on PONV (Type: EXPERIMENTAL): None
- Effect of infusion dexmedetomidine on PONV (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).